DIBASE sol 25000 UI 4 fl 2.5 ml
7680658570020
CH-65857
A11CC05
07.02.3.
Reimbursement limitations:
DIBASE
Traitement d'une carence sévère prouvée en vitamine D (concentration sérique de 25-hydroxycholécalciférol <25 nmol/l ou …
google
Details
- Product number
- 6585701
- CPT
- -
- Packaging group
- 4
- Unit
- Flasche(n)
- Composition
- cholecalciferolum 25000 U.I. corresp. cholecalciferolum 0.625 mg, olivae oleum raffinatum, ad solutionem pro 2.5 ml.
Articles (1)
DIBASE 25'000, Lösung zum Einnehmen
Lösung
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25000.0 UI | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.625 MG | Substance | WIIS |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 15.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
EffRx Pharmaceuticals SA
8807 Freienbach
Authorization information
- Swissmedic authorization number
- 65857
- Drug name
- DIBASE 25'000, Lösung zum Einnehmen
- Galenic form
- LSOR
- ATC Code
- A11CC05
- Authorization status
- Z
- Dispensation category
- B/D
- First authorization
- 13/07/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.02.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DIBASE sol 25000 UI 4 fl 2.5 ml
- Description (DE)
- DIBASE Lös 25000 IE 4 Fl 2.5 ml
- Market launch
- 13/07/2017
- Narcotic (BTM)
- No